{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cenerimod", "query": { "intervention": "Cenerimod" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 7, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T14:55:33.365Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05648500", "title": "A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Cenerimod", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 470, "start_date": "2022-12-13", "completion_date": "2027-05-01", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 22, "location_summary": "Huntington Park, California • Aurora, Colorado • Clearwater, Florida + 16 more", "locations": [ { "city": "Huntington Park", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05648500" }, { "nct_id": "NCT03742037", "title": "Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Cenerimod 0.5 mg", "type": "DRUG" }, { "name": "Cenerimod 1 mg", "type": "DRUG" }, { "name": "Cenerimod 2 mg", "type": "DRUG" }, { "name": "Cenerimod 4 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "cenerimod 2 mg (ex-4 mg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 427, "start_date": "2018-12-21", "completion_date": "2022-08-25", "has_results": true, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 29, "location_summary": "Anniston, Alabama • La Jolla, California • Los Alamitos, California + 25 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03742037" }, { "nct_id": "NCT02472795", "title": "Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Matching placebo", "type": "DRUG" }, { "name": "Cenerimod", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 105, "start_date": "2015-06-01", "completion_date": "2017-02-28", "has_results": true, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 2, "location_summary": "Anniston, Alabama • Clearwater, Florida", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02472795" }, { "nct_id": "NCT07201129", "title": "A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nephritis, Lupus", "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Cenerimod", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 300, "start_date": "2026-02-09", "completion_date": "2030-02", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 14, "location_summary": "Doral, Florida • Kissimmee, Florida • Miami, Florida + 7 more", "locations": [ { "city": "Doral", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07201129" }, { "nct_id": "NCT04052360", "title": "Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Cenerimod", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 20, "start_date": "2019-08-07", "completion_date": "2019-11-02", "has_results": false, "last_update_posted_date": "2025-09-22", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04052360" }, { "nct_id": "NCT05672576", "title": "A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Cenerimod", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 451, "start_date": "2023-06-26", "completion_date": "2027-05-01", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 17, "location_summary": "Tucson, Arizona • La Jolla, California • Northridge, California + 12 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05672576" }, { "nct_id": "NCT06475742", "title": "Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Cenerimod", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Innovation GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 680, "start_date": "2024-07-30", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-02T14:55:33.365Z", "location_count": 14, "location_summary": "Aurora, Colorado • Clearwater, Florida • DeBary, Florida + 8 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06475742" } ] }